Cassel Salpeter & Co. and its leadership team are routinely contacted by the news media to comment on investment banking, M&A and general trends affecting middle-market businesses.
In The News
Cassel Salpeter & Co. is an Independent Investment banking firm that provides advice to middle-market and emerging growth companies.
Get In Touch
Cassel Salpeter & Co.
801 Brickell Avenue,
Suite 1900
Miami, FL 33131
(305) 438-7700
Stay Informed
Sign up today for insights and growth strategies.
Subscribe Now
Biotech Bankruptcies Skyrocket
South Florida Investment Bankers Discuss Biotech Bankruptcies
Cassel Salpeter’s James Cassel and Ira Leiderman on healthcare industry drivers
QEP Completes Sale of United Kingdom Business
Florida Investment Bank Advises Board on Sale of UK Biz
Sale of QEP’s UK tool and accessory business assisted by Cassel Salpeter
Dry Powder Reserves Point to Insatiable Buyout Demand
Cassel Salpeter Chairman and Cofounder Talks 4th Quarter Deal Flow
South Florida investment banker James Cassel discusses factors driving midmarket M&A
Why Biopharma Companies Buy Stock in One Another
Cassel Salpeter Healthcare Investment Banker Considers IRA Impacts
South Florida investment bank managing director talks biologics R&D after IRA
Dealflow Continues to Drop, But Some are Optimistic for a Bounceback This Fall
Cassel Salpeter Chairman and Cofounder Talks 4th Quarter Deal Flow
South Florida investment banker James Cassel discusses factors driving midmarket M&A
IRA Creates Unintended Complications for Biologics
Cassel Salpeter Healthcare Investment Banker Considers IRA Impacts
South Florida investment bank managing director talks biologics R&D after IRA
Humira Biosimilars and Others Face Uncertain Future Under IRA
Cassel Salpeter Healthcare Investment Banker Weighs IRA Impacts
South Florida investment bank managing director discusses future of biosimilars after IRA
Blue Water Biotech makes the case for better mpox vaccines, even at ‘hyperlow endemicity’
Cassel Salpeter Healthcare Investment Banker Talks Mpox Vaccine
South Florida investment bank managing director considers viability of mpox vaccine development
‘We Don’t Have Enough of an Infrastructure’: Psychiatric Hospitals Buckling Under Historic Pressure
Cassel Salpeter Chairman and Cofounder Addresses Psychiatric Care Closings
South Florida investment banker James Cassel discusses what’s driving psychiatric services shutdowns
‘If There Is a Chilling Effect, It’ll Be Very Temporary’: What CARD’s Bankruptcy Means for the Autism Industry
Cassel Salpeter Chairman and Cofounder on CARD Bankruptcy
South Florida investment banker James Cassel discusses industry impacts of autism center Ch. 11
Athenex, Inc. Reaches Agreement With Lenders to Pursue Expedited Sales Process
South Florida Investment Bank Assists Global Cancer Therapy Creator in Bankruptcy
Cassel Salpeter provides investment banking services to biopharmaceutical company Athenex in Chapter 11
Startup funding will be more competitive after Silicon Valley Bank collapse
Cassel Salpeter Chairman on South Florida Tech Post-SVB Failure
South Florida investment bank founder James Cassel discusses future of South Florida tech economy
Banks seek to reassure South Florida depositors their accounts are safe
Cassel Salpeter Chairman and Cofounder on SVB Fallout
South Florida investment bank founder James Cassel discusses commercial lending post-SVB collapse
Deal Opportunities Still Exist in the Lower Middle-Market
Cassel Salpeter Chairman and Cofounder Talks Deals in the Lower Middle Market
South Florida investment banker James Cassel discusses M&A opportunities in a cautious marketplace
How to Prepare if Your Company is Being Acquired
Cassel Salpeter Healthcare Industry Investment Bankers On Getting Acquired
South Florida investment bank managing directors on best tips and practices following biotech acquisition
Trustee Makes Further Distribution in 1 Global Capital LLC, 1 West Capital LLC, Bankruptcy Cases
Miami Investment Banker Helps Creditors Receive Payment
Cassel Salpeter cofounder and chairman facilitates $6.9 million distribution to 3,750 creditors
Whether Fired or Tired, Young Guns Are Leaving Silicon Valley
Miami Investment Banker James Cassel Eyes Pressure on Unicorn Founders
Investment Banker James Cassel on Why Founders Leave After Their Companies Go Public
Moderna’s Second Act: is the Momentum Sustainable?
The potential for mRNA technology extends far beyond the COVID-19 vaccines that made it a household word.
Who’s Flying Now?
Miami Investment Banking Firm Director Talks Changing Private Aviation Space
South Florida’s Cassel Salpeter Aviation Director discusses how companies are addressing changes in private aviation
mRNA’s Next Act: Cancer Vaccines and Gene Editing
The potential for mRNA technology extends far beyond the COVID-19 vaccines that made it a household word.